Filing Details
- Accession Number:
- 0001358403-16-000238
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-07-29 17:48:14
- Reporting Period:
- 2016-07-27
- Filing Date:
- 2016-07-29
- Accepted Time:
- 2016-07-29 17:48:14
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1358403 | Bellicum Pharmaceuticals Inc | BLCM | Pharmaceutical Preparations (2834) | 201450200 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1627362 | M. David Spencer | C/O Bellicum Pharmaceuticals, Inc. 2130 W. Holcombe Blvd., Ste. 800 Houston TX 77030 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2016-07-27 | 10,000 | $15.00 | 176,082 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 21, 2016 by the Reporting Person.
- Includes 1,523 shares acquired under the Issuer's Employee Stock Purchase Plan on June 10, 2016.